This event has ended. Visit the official site or create your own event on Sched.

Psych Congress 2017

6:15pm CDT

Disrupting Mental Illness: Advancing Technologies, Improving Lives (Non-CME) Hall E-2

9:00am CDT

New Developments in Our Thinking about Personality Disorders Hall E-2

10:30am CDT

ADHD and Substance Use Disorders: An Intoxicating Combination Hall E-2

1:45pm CDT

Advancing the Long-Term Management of Substance Use Disorders Through Medication-Assisted Treatment Strategies Hall E-2

3:15pm CDT

Examining the Limitations of Monoamine-Directed Therapy in Major Depressive Disorder: Novel Mechanisms and Treatment Targets Hall E-2

9:15am CDT

Overcoming the 7 Common Perils of Telepsychiatry Hall E-2

10:45am CDT

Opioid Dependence: The Crossroads Between Pain and Addiction Hall E-2

2:45pm CDT

Optimizing Treatment in Schizophrenia: An Update Hall E-2

9:15am CDT

Pharmacological Augmentation of Evidence-Based Treatment for PTSD: Emerging Methods Toward the Individualization of Treatment Protocols Hall E-2

10:45am CDT

More Attention. Less Stimulants. Hall E-2

2:45pm CDT

The NYU Psilocybin Cancer Project Hall E-2

4:15pm CDT

Psychiatry Meets the Microbial World Hall E-2

9:15am CDT

The Promise and Perils of Ketamine in Psychiatric Practice Hall E-2

10:45am CDT

Dopamine Receptor Pharmacology: What We Clinicians Need to Know Hall E-2

1:45pm CDT

Out with the Old — In with the New: Novel, Neuroscience-Based Re-Classification of Psychiatric Medications Hall E-2

3:00pm CDT

Walk on the Wild Side or Walk on the Right Side? The Role of Psychedelics, Cannabinoids, and Opioids in Psychiatric Treatment Hall E-2

4:15pm CDT

Psych Congress 2017: Final Thoughts and Panel Discussion Hall E-2